1. Home
  2. CSPI vs VTGN Comparison

CSPI vs VTGN Comparison

Compare CSPI & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CSP Inc.

CSPI

CSP Inc.

HOLD

Current Price

$12.43

Market Cap

126.8M

Sector

Technology

ML Signal

HOLD

Logo VistaGen Therapeutics Inc.

VTGN

VistaGen Therapeutics Inc.

HOLD

Current Price

$4.27

Market Cap

122.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSPI
VTGN
Founded
1968
1998
Country
United States
United States
Employees
111
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
126.8M
122.1M
IPO Year
1987
N/A

Fundamental Metrics

Financial Performance
Metric
CSPI
VTGN
Price
$12.43
$4.27
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
13.5K
900.1K
Earning Date
12-05-2025
11-13-2025
Dividend Yield
0.93%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$57,298,000.00
$721,000.00
Revenue This Year
N/A
$54.26
Revenue Next Year
N/A
$478.23
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.65
$1.90
52 Week High
$21.95
$5.14

Technical Indicators

Market Signals
Indicator
CSPI
VTGN
Relative Strength Index (RSI) 64.60 51.99
Support Level $11.10 $3.36
Resistance Level $11.99 $4.97
Average True Range (ATR) 0.55 0.51
MACD 0.15 -0.05
Stochastic Oscillator 96.02 54.49

Price Performance

Historical Comparison
CSPI
VTGN

About CSPI CSP Inc.

CSP Inc along with its subsidiaries develops and markets IT integration solutions, security products, managed IT services, cloud services, purpose-built network adapters, and high-performance cluster computer systems. The firm operates in two segments namely Technology Solutions, where the company focus on value-added reseller integrated solutions including third-party hardware, software, and technical computer-related consulting, and High-Performance Products segments, where the company design, manufacture and deliver products and services to customers that require specialized cyber security services, networking and signal processing. It generates a majority of its revenue from the Technology Solutions segment. Geographically, the company generates its maximum revenue from the Americas.

About VTGN VistaGen Therapeutics Inc.

Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.

Share on Social Networks: